Evaluating biomarkers of neuronal degeneration and neuroinflammation in CSF of patients with multiple sclerosis-osteopontin as a potential marker of clinical severity.
Szalardy L, Zadori D, Simu M, Bencsik K, Vecsei L, Klivenyi P
J Neurol Sci. 2013 May 21. PMID: 23706476.Abstract